Sensus Healthcare, Inc. is a medical device company. Co. is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. Co. uses a low-energy X-ray technology known as superficial radiation therapy (SRT). Co. incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRTS average annual return since 2016 is shown above.
The Average Annual Return on the SRTS average annual return since 2016 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SRTS average annual return since 2016 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SRTS average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|
Free SRTS Email Alerts:
Video: Don't Forget Dividends in Average Annual Return!
